Physician profile
Kneisha Stapleton
NPI 1639849417
$1,340.02
in general payments reported to CMS, 2019-2025
10 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $454 · 2022: $290 · 2023: $12.78 · 2024: $224 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $241.39 | 2025 | Inspire |
| Alexion Pharmaceuticals, INC. | $237.17 | 2021-2022 | |
| Abbvie INC. | $184.29 | 2021-2022 | |
| Scynexis, INC. | $118.86 | 2022 | |
| Insmed, INC. | $118.33 | 2025 | Arikayce |
| Neurocrine Biosciences, INC. | $115.20 | 2024 | Ingrezza |
| Sage Therapeutics, LLC | $108.80 | 2024 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $103.20 | 2021 | |
| Therapeuticsmd, INC. | $100.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.78 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kneisha Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.